Moreover, Src tyrosine kinase has been suggested as a downstream target molecule in the c-Met cascades, and its inhibition in cancer cells can lead to reduced anchorage-independent growth, proliferation, survival, migration, invasion, metastasis and tumor vascularity [42]. The gene discussed is MET; the disease is neoplasm.